GAD2 and type 1 diabetes mellitus: T1D vaccine therapy, also known as autoantigen-specific immunotherapy, aims to restore immune tolerance and induce antigen-specific Tregs by targeted delivery of autoantigens (e.g., insulin, GAD65).